BayBio: IMPACT 2010 to Launch in January during JP Morgan

No where else in the world do three fundamental factors of a cluster converge as they do in California – VC investment, a world-class education system and an unparalleled entrepreneur ecosystem. Yet in 2009, VC investment was down and state funding for higher education was slashed.

BayBio: IMPACT 2010, the preeminent report on the state of California’s life sciences industry, outlines several steps the State and Federal government can undertake to increase capital flow and improve funding for education. As in years’ past, BayBio: IMPACT will be launched in San Francisco during JP Morgan with some of California’s leading executives to announce the vital steps to preserve California’s leadership in the life sciences industry.

In the midst of an economic downturn, competition from other states and countries, and the desire to inform opinion leaders, BayBio continues to push an agenda to improve the State’s business environment.

There are fundamental issues BayBio must address to influence opinion makers – education, infrastructure, regulatory affairs and healthcare reform.

BayBio has developed policies that are beneficial to the life sciences industry and are outlined in a 13-point action plan. Several issues will address healthcare reform and implementation, patent reform, reimbursement and energy policy amongst others.

In addition to the release of its new report, BayBio will launch a revamped website outlining the collective efforts of the entire life sciences industry in California. The comprehensive website will allow users to search the complete set of FDA-approved products of California origin, the companies who discovered them, and partners involved in bringing each product to the patients who need them.

The intent of the BayBio: IMPACT report is to increase employment opportunities, to streamline the regulatory process, to improve education opportunities for students at every level and to increase overall awareness for the life sciences industry. The report paints a new picture of life sciences research – one of treatments and cures reaching hundreds of millions of patients in the United States and the impact policy plays in the discovery of new treatments.

Join BayBio in the launch of BayBio: IMPACT 2010 on January 12. For more information, contact Travis Blaschek-Miller.